| Identification | Back Directory | [Name]
EGLIN C (41-49) | [CAS]
122299-11-0 | [Synonyms]
EGLIN C (41-49)
SER-PRO-VAL-THR-LEU-ASP-LEU-ARG-TYR
H-SER-PRO-VAL-THR-LEU-ASP-LEU-ARG-TYR-OH
SER-PRO-VAL-THR-LEU-ASP-LEU-ARG-TYR: SPVTLDLRY
(3S)-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[[(2S)-2-[[(2S,3R)-3-hydroxy-2-[[(2S)-3-methyl-2-[[ | [Molecular Formula]
C48H78N12O15 | [MDL Number]
MFCD00676937 | [MOL File]
122299-11-0.mol | [Molecular Weight]
1063.22 |
| Hazard Information | Back Directory | [Uses]
Eglin c (41-49) is a peptide fragment related to eglin c. Eglin c (41-49) shows inhibitory effects to cathepsin G and α-chymotrypsin with Ki values of 42 and 20 μM, respectively[1]. | [References]
[1] Okada Y, et al. Synthesis of peptide fragments related to eglin c and examination of their inhibitory effect on human leukocyte elastase, cathepsin G and alpha-chymotrypsin. Biochem Biophys Res Commun. 1989 May 30;161(1):272-5. DOI:10.1016/0006-291x(89)91591-x |
|
|